Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular and Cellular Endocrinology|February 7, 2012
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell lineA Vivaldi, R Ciampi, A Tacito, et al.Minerva Medica|September 1, 1988
[AIDS and the community. Preliminary data of an epidemiological study]R De Mercato, V Siciliano, S Formisano, et al.European Journal of Epidemiology|January 1, 1997
Prevalence of hepatitis C virus genotypes in southern ItalyS Cicciarello, G Borgia, J Crowell, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|October 1, 1990
[HCV and HBV infection in 3 communities in the Neapolitan area]R De Mercato, R Ciampi, D Guarnaccia, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|September 1, 1990
Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitisR De Mercato, R Ciampi, A Romano, et al.Journal of Endocrinological Investigation|August 19, 2016
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same glandR Ciampi, C Romei, L Pieruzzi, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|March 21, 2017
Targeted Therapy in Thyroid Cancer: State of the ArtL Valerio, L Pieruzzi, C Giani, et al.Endocrine-Related Cancer|August 4, 2011
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancerB Cosci, A Vivaldi, C Romei, et al.Pageof 2